Bush Nominates Acting NCI Chief For The Job
This article was originally published in The Pink Sheet Daily
President George W. Bush announced Aug. 16 that he will nominate acting National Cancer Institute Director John Niederhuber to succeed Andrew von Eschenbach, who left the position to head up FDA
You may also be interested in...
Acting commissioner defers when asked if he would accept a recess appointment to the FDA commissioner post, which would expire with the end of the next congressional season.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.